|Mr. Anthony Di Benedetto||Executive Chairman||N/A||N/A||1972|
|Mr. Richard Buzbuzian BA||President & Director||N/A||N/A||1971|
|Ms. Veronique Laberge CPA||CFO & Secretary||60,95k||N/A||1983|
|Mr. Nicky Canton||Chief Operating Officer||125,74k||N/A||1983|
|Ms. Karen Dunlap||Interim Chief Customer Officer & Director||7,55k||N/A||1948|
|Mr. Ian Heynen||Chief Executive Officer||N/A||N/A||N/A|
|Ms. Elisha Dillon||Head of Global Sales & Strategic Partnerships||N/A||N/A||N/A|
NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, semaglutide, and growth and fertility hormone, as well as DNA and conventional/pediatric vaccines. The company also offers InsuJet system that focus on servicing the diabetic community, as well as V5, V6, and V8 InsuJet injectors and sterile accessories. The company was formerly known as BuzBuz Capital Corp. NuGen Medical Devices Inc. is based in Toronto, Canada.
NuGen Medical Devices Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.